Medscape3d
Contribution of Interferon Gamma Release Assays Testing to the Diagnosis of Latent Tuberculosis Infection in HIV-infected Patients
Background: Diagnosis and treatment of latent tuberculosis infection (LTBI) is the most effective strategy to control tuberculosis (TB) among patients with HIV infection. The tuberculin skin test ...
Business Wire21d
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
This patent, which is one of many held by QIAGEN protecting the QuantiFERON technology, covers important innovations in QuantiFERON-TB Gold Plus that is used worldwide for TB detection.
Nasdaq20d
QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology
The patent, among several owned by QIAGEN that protect the QuantiFERON technology, encompasses significant innovations in the QuantiFERON-TB Gold Plus, which is employed worldwide for tuberculosis ...
Hosted on MSN5mon
QIAGEN's TB Testing Business Gets New Exposure at Global Summit
QIAGEN’s leading TB blood test, QuantiFERON-TB Gold Plus ... human immunodeficiency virus, or HIV-1, and human cytomegalovirus, or CMV, for use on the Panther instrument system.